U.S. President Donald Trump said on Tuesday he intends to impose a "25% or higher" levies on semiconductors and ...

VS Mani, CFO of Glenmark Pharma, discusses the company's strong performance in FY25 with an average of Rs 1,100 crore per ...

Glenmark Pharmaceuticals and FDC Ltd are withdrawing products in the US due to manufacturing problems, as per USFDA reports.

Glenmark Pharmaceuticals reported a net profit of Rs 348 crore for Q3FY25, a significant turnaround from a Rs 351 crore loss ...

KR Choksey is bullish on Glenmark Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1768 in ...

Glenmark Pharmaceuticals share price gained more than 5% during intraday trades on Monday post Q3 Results that were declared ...

Glenmark Pharmaceutical Ltd.'s shares rose over 5% during trade on Monday, after the management highlighted a 300.2% sales ...

Aditya Birla Fashion & Retail and Dish TV will be among 696 firms to release their reports for the Oct-Dec 2024 quarter ...

We expect our North America business to gain momentum from FY26 onwards, supported by our growing respiratory and injectable ...

As the market opens for a new trading day, here are some stocks that are in focus. From BHEL’s new contract to Glenmark ...

Pharma stocks experienced significant declines due to concerns over new tariffs. Notably, Dr Reddy's, Zydus Lifesciences, and Aurobindo Pharma saw the largest drops. US President Donald Trump's ...

The revenue from operations at Glenmark Pharma during Q3FY25 also marked a 35.1 per cent year-on-year (YoY) rise to Rs ...